Shilpa Medicare to expand bulk drug unit at Raichur in Karnataka with an investment of Rs. 218 million. The capacity of the project, after expansion will be 126.75 TPA. The expansion details of the new unit are as follows.
s. No. | Name of Products | Capacity (MTA) |
1 | Ambroxol HCI | 47 |
2 | Anastrozole | 0.1 |
3 | Bicalutamide | 0.5 |
4 | Carboplatin | 0.35 |
5 | Cisplatin | 0.1 |
6 | Coenzyme Q-10 | 18 |
7 | Docetaxel | 0.1 |
8 | Gemcitabine HCI | 0.3 |
9 | Irinotecan HCI Trihydrate | 0.1 |
10 | Oxaliplatin | 0.05 |
11 | Paclitaxel | 0.1 |
12 | Temozolomide | 0.1 |
13 | 3a, 7B-Dihydroxy Cholanic Acid | 60 |
Total | 126.8 |
Arihantanam Organics setting up a bulk drug unit at Sarigam in Valsad district of Gujarat with an investment of Rs. 5.0 million. The following products are herbal extracts and will be manufactured from natural sources.
Product No. | Products | Quantity in MTM |
1 | Quinine Sulphate |
|
2 | Quinine Hydro Chloride | 10.00 |
3 | Quinine di Hydro Chloride |
|
4 | Quinine bi Sulphate |
|
5 | Arteether |
|
6 | Artemether | 0.5 |
7 | Artesunate |
|
8 | Artemisinine |
|
SPC Lifescience to expand bulk drug unit at Ankleshwar in Bharuch district of Gujarat with an investment of Rs. 21.3 million. The expansion details of the new unit are as follows.
S. No | Products | Existing Capacity (MTM) | Proposed Increase (MTM) | After Expansion (MTM) |
Existing Products | ||||
1. | Dimethyl Amino Ethyl Chloride Hydrochloride OR Diethyl Amino Ethyl Chloride Hydrochloride OR Bis-Chloro Ethyl Amino Hydrochloride
| 20.0
20.0
20.0 | 0.0
0.0
0.0
| 20.0
20.0
20.0 |
2. | Mannich Hydrochloride
| 15.0 | 0.0 | 15.0 |
3. | Dimethyl Amino Propyl Chloride Hydrochloride solution
| 20.0 | 0.0 | 20.0 |
4. | Chloro Hexane-one
| 10.0 | 0.0 | 10.0 |
Additional New Products | ||||
1. | 4-(4-Fluorophenyl)-3-hydroxymethyl-1 methyl piperidine (BISCARBINOL) OR 4 Aryl-3-hydroxymethyl Piperidine
| 0.0 | 5.0 | 5.0 |
2. | 2 n - Butyl Benzofuran
| 0.0 | 3.0 | 3.0 |
3. | 2 n - Butyl 3 ( 4 - Hydroxy Benzoyl ) Benzofuran
| 0.0 | 2.5 | 2.5 |
4. | 2 n - Butyl 3 ( 3, 5 DI Iodo -4 - Hydroxy Benzoyl ) Benzofuran
| 0.0 | 4.0 | 4.0 |
5. | 3 Chloropropiophenone | 0.0 | 10.0 | 10.0 |
6.
| 2 - ( 2 Chloroethoxy ) Ethanol | 0.0 | 3.0 | 3.0 |
7. | 2 ( 2 Chloroethoxy ) Ethyl Acetate | 0.0 | 3.0 | 3.0 |
| Total | 65.0 | 30.5 | 95.5 |
By Products | ||||
1. | KBr Solution (From Butyl Benzofuran)
| 0.0 | 25.0 | 25.0 |
2. | Acetic acid (From Butyl Benzofuran) | 0.0 | 3.5 | 3.5 |
3. | Aq. AlCl3 (From Butyl Hydroxy Benzoyl Benzofuran, 3- Chloropropiophenone )
| 0.0 | 117.0 | 117.0 |
4. | Aqueous Sodium Iodide
| 0.0 | 19.0 | 19.0 |
| Total | 0.0 | =SUM(ABOVE) 164.5 | 164.5 |
The Existing Gas Consumption is 350 NM3/Day which will increase to 1250 NM3/Day. The existing unit has one LDO based D. G. Set of 62.5 KVA and one more of 250 KVA based on natural gas is proposed. The total Power requirement of 500 KVA is met through DGVCL (State Electricity Board) supply.
RPG Life Science to modernize its bulk drug unit at Ankleshwar in Bharuch district of Gujarat with an investment of Rs. 20 million. The project also involves expanding the present production capacity of Bulk Drugs from 83.3 kg/ month (1.0 TPA) to 150.0 kg/m (1.8 MTA) as per the following details-
S.No. | Name of the product | Existing | Proposed | Total |
1 | 64.2 | 31.8 | 96.0 | |
2 | Mycophenolate Mofetil | 42.5 | 47.5 | 90.0 |
3 | Daunomycin Hydrochloride | 33.3 | Nil | 33.0 |
4 | Daxorubicin Hydrochloride | 20.0 | Nil | 20.0 |
5 | Epirubicin Hydrochloride | 6.0 | Nil | 6.0 |
6 | Lovastatin | 70.8 | Nil | 70.8 |
7 | Pravastatine | 69.0 | Nil | 69.0 |
8 | Orlistat | 49.5 | Nil | 49.5 |
9 | Hyluronic Acid | Nil | 52.8 | 52.8 |
10 | Methyl Cobalamine | Nil | 25.0 | 25.0 |
11 | Idarubicin | Nil | 6.0 | 6.0 |
12 | Pirarubicin | Nil | 6.0 | 6.0 |
13 | Tachrolimus | Nil | 108.0 | 108.0 |
14 | Sirolimus (Rapamycin) | Nil | 108.0 | 108.0 |
15 | 11-Alpha hydroxy Canrenon | Nil | 134.4 | 134.0 |
| Total | 83.3 | 66.7 | 150.0 |
11,950 ₹ | 4950 ₹ | 4950 ₹ | 4950 ₹ | 3950 ₹ |
Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202 Mobile : 0-97898-37940 email : [email protected] Privacy Policy